Your Partner for
Healthcare Investing Biotech Innovation Medtech Breakthroughs Powering Israeli Healthtech First-in-Class Science Founder-First Partnerships Building Great Companies Scaling Your Venture From Lab to Market Global Market Access Conviction Capital
Your Partner for
Eliraz Ventures invests in the best-of-the-best healthcare startups in Israel
The pace of scientific innovation has never been faster. We are at the dawn of a new era defined by AI in drug discovery, "disease reset" cell and gene therapies, and RNA therapeutics, among others.
Israel is a global epicenter for this innovation. Its robust ecosystem - a powerful combination of world-class academic centers, a deep talent pool, serial entrepreneurs, and experienced investors - consistently generates first-in-class, disruptive healthcare companies.
This environment is ripe for investment, and Eliraz Ventures exists to partner with Israel's most brilliant founders to turn that science into world-changing companies.
Our Guiding Principles
Our investment thesis is built on a foundation of core values. These principles guide every decision we make and every partnership we build.
We are long-term partners, not just investors.
We succeed only when our founders succeed.
_4x.png)
We believe in disruptive science with real-world impact.
We seek visionary ideas that can fundamentally change the standard of care.
We build bridges, not silos.
We connect Israel's best innovators to our global ecosystem of experts, partners, and markets.
We act with conviction and integrity.
We are committed to building great companies and generating outsized returns, the right way.
Our Team
We are more than an emerging fund; our strength lies in our managers, who have successfully led organizations, built companies, and demonstrated strong collaborations.
Nissim Darvish
Nissim brings extensive leadership experience from top-tier firms, including the global healthcare powerhouse Orbimed and Israel's most established multi-stage VC, Pitango. He is a proven ecosystem and company builder, co-chairing Israel's largest life sciences conference (BioMed) and contributing to the IPOs of companies like Neovasc and ChemoMab. As an inventor and scientist (MD, PhD) with 100+ patents, he combines deep scientific, investment, and M&A acumen.
Ari Fried
Ari provides valuable insights from his roles at JJDC (Johnson & Johnson's strategic venture arm) and Triventures, a pioneering US/Israeli VC. His expertise spans seed-stage startups, corporate venture, and business development. Ari employs an integrated investment approach, assessing people, clinical impact, market potential, and regulatory pathways to "reverse engineer" exit opportunities. His background in biology, physics, and corporate finance provides a 360-degree view of the investment lifecycle.
Healthcare’s Cambrian Explosion:
A New Era of Medicine
We are on the cusp of a healthcare revolution, driven by urgent needs and breakthrough technologies.
Aging populations are straining health systems worldwide, making prevention and early intervention critical to our future.
Urgent Global Need
A massive "pharma patent cliff" is putting billions in sales at risk between. Now more than ever big pharma will look to acquire the next generation of innovation we are funding today.
M&A-Driven Future
Disease Reset: We are moving from treatment to cure. Innovations in cell and gene therapy are unlocking the potential to "turn back the clock" on immune systems or deliver curative interventions for genetic conditions.
AI-Driven Discovery: AI is shortening the drug development process by years, helping to identify novel drug targets and optimize them in silico.
RNA Therapeutics: New RNA platforms are enabling infrequently administered therapies that could solve preventative care and adherence.
Technological Leaps
Advancements in diagnostics and novel treatments are enabling us to intervene in complex diseases like cancer at much earlier stages — potentially avoiding hospitalization and significantly improving patient outcomes at lower costs.
Earlier Intervention
Israel: An Epicenter of Innovation
Israel is a small country with a giant impact. It is the ideal ecosystem for building the future of healthcare.
Israel is consistently in the top percentile globally in startups per capita and in the highest R&D expenditure per capita.
A True "Startup Nation
The healthcare ecosystem boasts over a thousand active companies and a deep well of mature, experienced leadership.
Deep Talent Pool
Israel has one of the world's highest concentrations of AI-skilled professionals. The convergence of AI and biology will be a key driver of the next generation of healthtech.
The Forefront of AI
Despite market cycles, Israel is a strong source of perpetual innovation. Multinational corporations and global industry stalwarts consistently acquire, license, and partner with Israeli companies to build the next generation of healthcare solutions.
Proven Resilience & Exits
Key Success Factors
We don't just invest. We build. Our process is built on three pillars:
Sourcing
We find companies others can't. Our team's decades in the ecosystem, leadership roles in flagship companies, and access to serial entrepreneurs create a trusted, high-quality deal flow.
Selecting
We look for true fund-returners. We analyze the team, the clinical and financial impact, and the potential avenues to liquidity from day one. We use an AI-powered VC platform to screen more applicants, filter opportunities, and expedite diligence, giving us a significant advantage.
Servicing
We go beyond capital to act as an extension of the founding team. We provide hands-on strategic support and de-risk our ventures by leveraging global partners for critical IP due diligence, global regulatory strategy, and new market access into Asia and the Middle East.
Our Ecosystem
Our value-add is built on a foundation of deep, global relationships. We provide our portfolio companies with an unfair advantage by connecting them to our curated ecosystem of world-class experts and strategic partners. Our network includes:
We provide access to world-renowned IP experts who help build and protect your most valuable assets, as well as global regulatory science leaders who design optimal pathways to market.
Global Industry Strategists
1
We build bridges from Israel to the world, leveraging deep partnerships and local expertise in the key commercial markets of the United States, Asia, and the Middle East.
Global Market Access
2
We maintain strong relationships with leading VCs across the globe. This allows us to build powerful, aligned syndicates that provide the capital and connections needed to scale.
Top-Tier Syndicate Partners
3
For Founders
We are built to be your partner, not just your investor. We know that building a world-changing healthcare company requires more than just capital — it requires a shared mission, deep domain expertise, and a network that can open doors.
We partner with resilient, mission-driven founders who are using disruptive science to solve the world's biggest healthcare challenges.
What We Look For
-
Visionary Teams: Serial entrepreneurs, experienced operators, and deep scientific experts with the grit and vision to build a category-defining company.
-
Disruptive Science: First-in-class, novel platforms and technologies (therapeutics, medtech, or healthtech) with the potential for outsized clinical and financial impact.
-
Clear Value Proposition: A fundamental understanding of the market, the clinical need, and the "reverse-engineered" path to a successful exit.
Our Partnership Model
-
Active Support: We are an extension of your team. We take an active, hands-on role in helping you navigate challenges and build your strategy.
-
Global Leverage: We connect you with our global ecosystem of specialized experts and strategic partners to help you de-risk and accelerate growth.
-
Syndicate Building: We lead, but we also co-invest. We leverage our deep relationships with top-tier VCs in the US, EU, and Asia to build powerful syndicates that set you up for long-term success.
If you are an Israeli founder building the future of healthcare, we want to hear from you.
Partner With Us
We are always looking for the next generation of category-defining healthcare companies. If you are an Israeli founder building a disruptive solution in Biotech, Medtech, or Healthtech, we want to hear from you.
Please share a brief overview of your venture. We read every submission, but due to the high volume of inquiries, we prioritize teams that align with our core investment thesis: disruptive science, strong leadership, and a clear path to market.
